Details of the Drug | DrugMAP

General Information of Drug (ID: DMA3W2D)

Drug Name

XXB750

Indication

Disease Entry	ICD 11	Status	REF
Hypertension	BA00-BA04	Phase 2	[1]
Heart failure with preserved ejection fraction	BD11.0	Phase 1	[2]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D84KSZ

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT05562934) A Multi-center, Randomized, Double-blind, Parallel-group, 20-week Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of XXB750 in Patients With Resistant Hypertension. U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT05328752) A Randomized, Participant- and Investigator-blinded, Sponsor Open-label, Placebo-controlled, Single and Multiple Dose Study to Investigate the Safety and Tolerability of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF). U.S.National Institutes of Health.